NIH grants $2.3M to evaluate the impact of ViTrack® on maternal and child health during pregnancy
News Provided by Dynocardia, Feb 20, 2024 The study addresses a long-standing unmet need for wearable technology to facilitate the accurate diagnosis of high blood pressure and early detection of preeclampsia, a leading cause of complications and mortality during pregnancy. "ViTrack technology offers a new and unprecedented ability to continuously measure blood pressure and other critical heart and [...]